Clinical Trial Update: Study of ESG401 in Adults With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on ESG401 in adults with solid tumors, spanning Phase 1 and Phase 2. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Ovarian Cancer
• Stomach Cancer

Drugs mentioned

• ESG401

Snippet

Sponsor: Shanghai Escugen Biotechnology Co., Ltd | Conditions: Neoplasms, Breast, Neoplasms, Lung | Phase 1, Phase 2 | Status: COMPLETED